NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VeriSIM Life

VeriSIM Life

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.verisimlife.com/

Last Round

Grant

Apr 19, 2022

Total Funding Raised

$22.27M

Company Overview

VeriSIM Life is a biotechnology company that provides an AI-enabled biosimulation platform to de-risk R&D decisions and accelerate drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoveryin silicobiosimulationclinical trial predictiontranslational modelingmodel-informed drug developmentMIDDAI drug discoverydigital twinSaaSpredictive analyticsR&D optimizationbiotech softwarefail faster

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VeriSIM Life Comparables

Compare VeriSIM Life with similar companies based on industry and business-model similarity.

VeriSIM Life comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bioleap
80%
Cellworks Group Inc
78%
DeepCyte
78%

VeriSIM Life Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 19, 2022
Series AJan 6, 2022
GrantMar 2, 2021
SeedAug 14, 2019
Pre SeedDec 1, 2017

Key People

Founding team and executive leadership

Jo Varshney

Founder & CEO

Founding Team

VeriSIM Life Investors

Notable investors and investment history

VeriSIM Life investors
InvestorRounds
National Institute on Drug AbuseGrant
Twin VenturesSeed
Global VillageSeed
NIH RADxGrant
TenOneTen VenturesPre Seed
Serra VenturesSeries A, Seed
Intel CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    Won the AI in Action Award at the Reuters Global Pharma Awards.

  • Sep 22, 2025

    Shortlisted for the Innovation Award at the 2025 Scrip Awards.

VeriSIM Life Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VeriSIM Life Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VeriSIM Life's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range19
Year Founded2017
Last FundingApr 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.